SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-006896
Filing Date
2023-03-16
Accepted
2023-03-16 16:11:07
Documents
15
Period of Report
2023-03-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20230315_8k.htm   iXBRL 8-K 29862
2 EXHIBIT 99.1 ex_489485.htm EX-99.1 173108
7 ex_489485img001.jpg GRAPHIC 5293
  Complete submission text file 0001437749-23-006896.txt   359372

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbla-20230316.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20230316_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20230316_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20230316_pre.xml EX-101.PRE 11688
9 EXTRACTED XBRL INSTANCE DOCUMENT pbla20230315_8k_htm.xml XML 2553
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 23738886
SIC: 2834 Pharmaceutical Preparations